Organon to publish Q3 2026 results in its routine 10-Q report
Organon will publish Q3 2026 results in its routine 10-Q filing; earnings calls remain suspended during the pending Sun Pharma acquisition.
- published
- in the api
- on the website
on the website stories appear 15 minutes after publication, in the api at once. connect the api →
what happened
Organon intends to share its third-quarter 2026 figures in the periodic 10-Q report it sends to the SEC each quarter. The company will also disclose adjusted financial measures and their reconciliation to standard GAAP numbers in an 8-K filed the same day, according to the original release distributed via TradingView.
The company also said it currently anticipates no milestone payments being booked during the July to September period. The quarterly numbers are still subject to closing procedures and may differ from the preliminary estimates provided.
why it matters
The news is largely procedural: results will arrive on the usual schedule, but without earnings calls while the Sun Pharma acquisition is pending. Investors will rely on SEC filings rather than management commentary. Market relevance is limited, although progress on the deal remains the main driver for the stock.
tags
instruments
sources
- Organon to Report Third Quarter 2026 Results in Its Regularly Scheduled Form 10-Q Filing — TradingView, 19 October 2026 at 11:30 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
on the website stories appear 15 minutes after publication, in the api at once.
get stories in real time ↗